Veerhealth Care Ltd.

28.78 +2.10 ▲7.9%

23 February 2024, 04:01:00 PM
Volume: 5,002,099

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website https://veerhealthcare.net/
Market Cap 57.56 Cr.
Enterprise Value(EV) 57.56 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.99 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 29.22 Trailing Twelve Months Ending 2023-12
Industry PE 41.88 Trailing Twelve Months Ending 2023-12
Book Value / Share 11.19 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.57 Calculated using Price: 28.78
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.00 Cr. 19,998,476 Shares
FaceValue 10
About Veerhealth Care Ltd.
The company is engaged in the business of trading and manufacturing and marketing research-based Ayurvedic medicines.

Veerhealth Care Ltd. Delivery

Delivered Qty
Traded Qty

Veerhealth Care Ltd. Performance

1 Day
+7.87%
1 Week
+27.40%
1 Month
+35.05%
3 Month
+58.22%
6 Month
+36.08%
1 Year
+149.83%
2 Year
+466.54%
5 Year
+695.03%
10 Year
+195.18%

Veerhealth Care Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.45 0.07 0.18 1.06 1.2 2.35 2.73 -0.53 8.94
Return on Capital Employed (%) 1.62 1.13 1 2.38 2.89 5.5 4.97 2.17 6.32
Return on Assets (%) 0.42 0.06 0.17 0.99 1.02 1.86 2.07 -0.38 6.97

Veerhealth Care Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 13 13 13 13 14 14 14 21 22
Non Curr. Liab. 1 1 1 0 0 3 3 4 3 1
Curr. Liab. 1 1 0 1 3 1 2 2 1 1
Minority Int.
Equity & Liab. 14 14 13 15 16 18 19 20 25 24
Non Curr. Assets 6 7 5 8 13 12 12 14 15 14
Curr. Assets 8 7 8 7 3 6 7 6 10 10
Misc. Exp. not W/O 0
Total Assets 14 14 13 15 16 18 19 20 25 24

Veerhealth Care Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1 2 2 5 6 12 11 10 13 14
Other Income 0 0 1 1 0 0 1 2 1 1
Total Income 2 3 3 6 6 12 12 11 15 15
Total Expenditure -1 -2 -2 -5 -6 -11 -11 -10 -13 -13
PBIDT 0 0 0 1 1 1 1 1 2 2
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 2 2
Adjusted EPS 0 0 0 0 0 0 0 0 1 1

Veerhealth Care Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 -4 2 2 2 0 1 2 -1
Cash Fr. Inv. -4 4 0 0 -3 -2 -2 0 -1 -2
Cash Fr. Finan. -1 1 0 2 -1 0 6
Net Change 0 0 0 0 0 0 0 0 0 3
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 4

Veerhealth Care Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 41.93 42.34 44.31 44.36 44.36 30.76 30.76 30.76 30.76
Public 58.07 57.66 55.69 55.64 55.64 69.24 69.24 69.24 69.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Veerhealth Care Ltd. Announcements

Thu, 22 Feb 2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Veerhealth Care Limited is pleased to announce that the Company have approved expansion project to enhance healthcare solutions.Please find enclosed herewith a copy of Press Release giving information about the same.
Wed, 21 Feb 2024
Announcement Under Regulation 30 (LODR) - Additional Details Pursuant To SEBI Circular Dated July 13 2023 And Regulation 30 Of SEBI (LODR) Regulations 2015
In continuance of announcement of Outcome of Board Meeting dated 20th February 2024 please find attached herewith the additional details pursuant to SEBI Circular dated July 13 2023 and Regulation 30 of SEBI (LODR) Regulations 2015.
Tue, 20 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting
This is to inform you that the Board of Directors of the Company at its meeting held today i.e. 20th February 2024 inter alia has approved the following:1. The Board has approved expansion project and estimated project cost for expansion will be Rs. 33 Crores including purchase of Land Construction of Building Plant & Machinery and other Infrastructure.2. Out of Rs. 33 Crores Rs. 8 Crores to be raised from bank by way of borrowings.3. Board has decided to issue new 99 99 238 equity shares having face value of Rs. 10/- each at a premium of Rs. 15/- per share by way of Rights Issue to the existing shareholders of the Company at an issue price of Rs. 25/- per equity share in the ratio of 1:2 i.e. 1 (one) new Right Share for every 2 (two) existing Equity Shares held by the eligible shareholders.The Board Meeting commenced at 3.00 p.m. and concluded at 4.00 p.m.

Veerhealth Care Ltd. Technical Scans

Fri, 23 Feb 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing 52 Week High Close Crossing 52 Week High
Closing Above Previous High Closing Above Previous High

Veerhealth Care Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Veerhealth Care Ltd. FAQ's

What is Veerhealth Care share price?

Can I buy Veerhealth Care shares now?

What is the Market Cap of Veerhealth Care?

What are the key metrics to analyse Veerhealth Care?

What is the 52 Week High and Low of Veerhealth Care?

What is the trend of Veerhealth Care share price?